Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2012

Feb 1, 2012

33819_dirs_2012-01-31_90b43416-dd10-44db-8977-818cf9bbdedf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-01-27

Reporting Person: Stratton Kenneth Blair (General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-01-27 Common Stock A 130000 $0.00 Acquired 157529 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4062 Indirect

Footnotes

F1: Restricted stock units, with 1/4 vesting on January 27, 2013, 1/4 vesting on January 27, 2014, 1/4 vesting on January 27, 2015, and 1/4 vesting on January 27, 2016.

F2: Includes (1) 130,000 restricted stock units, with 32,500 of this vesting on each of January 27, 2013, January 27, 2014, January 27, 2015, and January 27, 2016; (2) 15,000 restricted stock units, with 5,000 vesting on each of June 1, 2012, June 1, 2013, and June 1, 2014; and (3) 4,667 restricted stock units, with 2,333 vesting on each of May 15, 2012 and May 15, 2013. Amounts reflect automatic adjustments under applicable benefit plans triggered by issuer's 1 for 10 reverse stock split.

F3: Includes shares held in 401(k) account in accordance with issuer's employer-match policies.